Posted by Michael Wonder on 03 Aug 2022
TGA commences evaluation of Pfizer's COVID-19 vaccine (Comirnaty) for children aged 6 months to less than 5 years
3 August 2022 - The TGA has commenced evaluation of an application from Pfizer to extend the use of its COVID-19 vaccine (Comirnaty) to use in a three dose course in children aged 6 months to less than 5 years old.
Currently this vaccine is provisionally approved for immunisation to prevent COVID-19 in individuals aged 5 years and older as a primary course and as a booster dose for those aged 12 years and older. A lower dose (3 mcg/0.2 mL) of the vaccine will be assessed for younger children.
